0.66 USD
▲+0.03+5.53%
盘后 0.61 -2.46%
2026-08-03
市值
$61.37M
市盈率
—
EPS
-0.50
股息率
—
52 周区间
0.49 – 2.25
成交量
74.13K
Beta
3.50
目标价
—
52W 低 0.4952W 高 2.25
价格走势
公司简介
Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Leonard-Meron Biosciences, Inc.